- Home
- BHFAO vs SNN Comparison
BHFAO vs SNN Comparison
Compare BHFAO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHFAO
- SNN
- Stock Information
- Founded
- BHFAO N/A
- SNN 1856
- Country
- BHFAO United States
- SNN United Kingdom
- Employees
- BHFAO 1400
- SNN N/A
- Industry
- BHFAO Life Insurance
- SNN Industrial Specialties
- Sector
- BHFAO Finance
- SNN Health Care
- Exchange
- BHFAO Nasdaq
- SNN Nasdaq
- Market Cap
- BHFAO N/A
- SNN 13.2B
- IPO Year
- BHFAO N/A
- SNN 1999
- Fundamental
- Price
- BHFAO $18.45
- SNN $30.28
- Analyst Decision
- BHFAO
- SNN Hold
- Analyst Count
- BHFAO 0
- SNN 3
- Target Price
- BHFAO N/A
- SNN $27.50
- AVG Volume (30 Days)
- BHFAO N/A
- SNN 1.2M
- Earning Date
- BHFAO N/A
- SNN 07-31-2025
- Dividend Yield
- BHFAO N/A
- SNN 2.37%
- EPS Growth
- BHFAO N/A
- SNN 56.15
- EPS
- BHFAO N/A
- SNN 0.47
- Revenue
- BHFAO N/A
- SNN $5,810,000,000.00
- Revenue This Year
- BHFAO N/A
- SNN $6.87
- Revenue Next Year
- BHFAO N/A
- SNN $5.19
- P/E Ratio
- BHFAO N/A
- SNN $33.29
- Revenue Growth
- BHFAO N/A
- SNN 4.70
- 52 Week Low
- BHFAO N/A
- SNN $23.69
- 52 Week High
- BHFAO N/A
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- BHFAO 32.05
- SNN 54.96
- Support Level
- BHFAO $18.88
- SNN $29.50
- Resistance Level
- BHFAO $19.54
- SNN $31.43
- Average True Range (ATR)
- BHFAO 0.74
- SNN 0.42
- MACD
- BHFAO -0.12
- SNN 0.02
- Stochastic Oscillator
- BHFAO 1.03
- SNN 56.27
About BHFAO Brighthouse Financial Inc. Depositary Shares 6.75% Non-Cumulative Preferred Stock Series B
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.